跳至主要内容
临床试验/JPRN-UMIN000050754
JPRN-UMIN000050754招募中Unknown

Genetic Alterations and clinical record in surgically debulked OVarian cancer patients by Liquid biopsy And whole eXome analYsis - GALAXY-OV trial

ational Cancer Center0 个研究点目标入组 150 人开始时间: 2023年4月3日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18years-old 至 ot applicable(—)
性别
Female

入选标准

  • 未提供

排除标准

  • 1.Patients with a history of treatment with PARP inhibitors or bevacizumab. 2.Patients who plan to use bevacizumab for preoperative adjuvant chemotherapy. 3.Persons with a history of malignancy(*6) (*6)Patients with a recurrence-free period of at least 5 years or with basal or spinous cell carcinoma of the skin, superficial bladder cancer, cervical cancer, carcinoma in situ (intraepithelial carcinoma) or intramucosal carcinoma equivalent lesions that are considered cured by local treatment may be enrolled. 4.Persons with active local or systemic infections requiring treatment. 5.Persons who are HBs antigen positive, HBc antibody positive(*7) or HCV antibody positive(*8) (*7) HBc antibody positive, but HBV-DNA negative is acceptable for registration. (*8) HCV antibody-positive but HCV-RNA-negative patients are eligible for registration. 6.Must be HIV antibody positive (HIV antibodies may be untested for registration). 7.Patients with a history of interstitial lung disease requiring treatment (interstitial pneumonia, pulmonary fibrosis, etc.) or extensive findings of these diseases on CT. 8.Patients with uncontrolled complications(*8). (*8)Gastrointestinal bleeding, cardiac disease, glaucoma, diabetes, etc. 9.Patients receiving continuous systemic administration (oral or intravenous) of steroids (prednisolone equivalent of 10 mg/day or more for at least 2 weeks) 10.Persons who are judged to have difficulty enrolling in this study due to clinically problematic psychiatric disorders. 11.History of hemoptysis (sputum of 2.5 mL or more of fresh blood). 12.Pregnant or lactating women. 13.Other persons who are deemed by the physician in charge to be unsuitable for enrollment in this study.

研究者

发起方
ational Cancer Center

相似试验